THAR · Tharimmune
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
Market Cap
187.4M
52 Wk Range
$0.95 - $9.08
Previous Close
$2.24
Open
$2.24
Volume
467,844
Day Range
$2.24 - $2.37
Enterprise Value
191.4M
Cash
17.03M
Avg Qtr Burn
-10.44M
Insider Ownership
22.66%
Institutional Own.
22.24%
Qtr Updated
Dec 31st 2025
